http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0853947-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aed88886dfb069fc837deb10321185f0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-59
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-00
filingDate 1997-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7de5358407542320950a90f4c10129b0
publicationDate 1998-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0853947-A1
titleOfInvention Matrix material comprising several bio-active materials
abstract The invention relates to a matrix materialnprovided with a number of bio-active materials, innparticular drugs, comprising a substrate,npolyethyleneimine (PEI) coupled to the substrate, andnseveral bio-active materials adhering to thenpolyethyleneimine and/or substrate. n The matrix material can be obtained by thenfollowing steps:n (a) preparing, if necessary, the substrate fornthe introduction of coupling groups; (b) effecting contact between the substrate andna solution of PEI, if required in the presence of ancarbodiimide; and (c) subsequently effecting contact between thensubstrate treated with PEI and one or more solutions ofnbio-active materials, if required in the presence of a
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105137064-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0930331-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0930331-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10036907-B4
priorityDate 1996-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4786556-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9707834-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2257147-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5532311-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5132108-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0351314-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8302954-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15908
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136069385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226745004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128116760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53897726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22592695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226699355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14048665

Total number of triples: 38.